{"transactions":[{"id":704223,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-07-23T20:46:05.000Z","date":"2026-07-22","kind":"grant","planned":false,"acquired":true,"shares":1190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders."}],"balance_after":1190,"derivative":{"exercise_price":527.07,"exercise_date":"2027-06-25","expiration_date":"2033-07-22","underlying":"Common Stock","underlying_shares":1190},"source":{"system":"sec-edgar","filing":"0001822674-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000182267426000004/primarydocument.xml","form_type":"4"}},{"id":704222,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-07-23T20:46:05.000Z","date":"2026-07-22","kind":"grant","planned":false,"acquired":true,"shares":380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable as restricted stock units do not have an expiration date."}],"balance_after":380,"derivative":{"exercise_price":0,"exercise_date":"2027-06-25","underlying":"Common Stock","underlying_shares":380},"source":{"system":"sec-edgar","filing":"0001822674-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000182267426000004/primarydocument.xml","form_type":"4"}},{"id":742971,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T00:11:36.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":65600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 9, 2027 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":65600,"derivative":{"exercise_price":7.25,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":65600},"source":{"system":"sec-edgar","filing":"0001822674-26-000003","document":"wk-form4_1781136692.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000182267426000003/wk-form4_1781136692.xml","form_type":"4"}},{"id":1080854,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-07-28T10:25:11.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":3650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director award."}],"balance_after":3650,"derivative":{"exercise_price":306.41,"exercise_date":"2026-07-09","expiration_date":"2035-07-24","underlying":"Common Stock","underlying_shares":3650},"source":{"system":"sec-edgar","filing":"0001562180-25-005527","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025005527/primarydocument.xml","form_type":"4"}},{"id":1104892,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-20T22:34:29.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":162786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 18, 2026 or the date immediately preceding the Issuer's next annual meeting of stockholders."}],"balance_after":162786,"derivative":{"exercise_price":2.84,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":162786},"source":{"system":"sec-edgar","filing":"0001326110-25-000091","document":"wk-form4_1750458862.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000091/wk-form4_1750458862.xml","form_type":"4"}},{"id":1448249,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-26T20:30:20.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":2890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These awards vest on the one-year anniversary of the grant date."}],"balance_after":2890,"derivative":{"exercise_price":336.37,"exercise_date":"2025-07-25","expiration_date":"2034-07-25","underlying":"Common Stock","underlying_shares":2890},"source":{"system":"sec-edgar","filing":"0001415889-24-020168","document":"form4-07262024_040717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020168/form4-07262024_040717.xml","form_type":"4"}},{"id":1480428,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T22:49:04.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":77633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 11, 2025 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":77633,"derivative":{"exercise_price":5.96,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":77633},"source":{"system":"sec-edgar","filing":"0001326110-24-000076","document":"wk-form4_1718318936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000076/wk-form4_1718318936.xml","form_type":"4"}},{"id":1828971,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-07-17T10:30:23.000Z","date":"2023-07-13","kind":"grant","planned":false,"acquired":true,"shares":4560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":4560,"derivative":{"exercise_price":229.81,"exercise_date":"2024-07-13","expiration_date":"2033-07-13","underlying":"Common Stock","underlying_shares":4560},"source":{"system":"sec-edgar","filing":"0001415889-23-011156","document":"form4-07172023_060718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923011156/form4-07172023_060718.xml","form_type":"4"}},{"id":1854137,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T22:29:09.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":158263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 13, 2024 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":158263,"derivative":{"exercise_price":2.99,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":158263},"source":{"system":"sec-edgar","filing":"0001326110-23-000089","document":"wk-form4_1686868141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000089/wk-form4_1686868141.xml","form_type":"4"}},{"id":2210152,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-07-08T21:47:02.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":4980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":4980,"derivative":{"exercise_price":240.2,"exercise_date":"2023-07-07","expiration_date":"2032-07-07","underlying":"Common Stock","underlying_shares":4980},"source":{"system":"sec-edgar","filing":"0001415889-22-007605","document":"form4-07082022_020752.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922007605/form4-07082022_020752.xml","form_type":"4"}},{"id":2231333,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T01:24:26.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":167937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 14, 2023 or the date immediately preceding the 2023 annual meeting of stockholders."}],"balance_after":167937,"derivative":{"exercise_price":2.98,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":167937},"source":{"system":"sec-edgar","filing":"0001326110-22-000051","document":"wf-form4_165534265138039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611022000051/wf-form4_165534265138039.xml","form_type":"4"}},{"id":2254088,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-05-27T20:32:11.000Z","date":"2022-05-27","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18680,"derivative":{"exercise_price":102.44,"exercise_date":"2021-09-10","expiration_date":"2030-09-10","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001415889-22-005814","document":"form4-05272022_040545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005814/form4-05272022_040545.xml","form_type":"4"}},{"id":2254087,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T20:32:11.000Z","date":"2022-05-27","kind":"sale","acquired":false,"shares":2000,"price":228,"value":456000.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-005814","document":"form4-05272022_040545.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005814/form4-05272022_040545.xml","form_type":"4"}},{"id":2254086,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T20:32:11.000Z","date":"2022-05-27","kind":"exercise","acquired":true,"shares":2000,"price":102.44,"value":204880.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-22-005814","document":"form4-05272022_040545.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005814/form4-05272022_040545.xml","form_type":"4"}},{"id":2637250,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true}}],"security":"Stock Options","published_at":"2021-07-09T20:54:27.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":6450,"price":183.98,"value":1186671.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the first board meeting following the issuer's Annual Meeting of Shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":6450,"derivative":{"exercise_price":183.98,"exercise_date":"2022-07-08","expiration_date":"2031-07-08","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001127602-21-021763","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221021763/form4.xml","form_type":"4"}},{"id":2669969,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T22:35:03.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":26064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 10, 2022 or the date immediately preceding the 2022 annual meeting of stockholders."}],"balance_after":26064,"derivative":{"exercise_price":14.91,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":26064},"source":{"system":"sec-edgar","filing":"0001209191-21-040351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121040351/doc4.xml","form_type":"4"}},{"id":2726956,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-05T22:05:37.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":21873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, the shares subject to the award will vest in three (3) equal installments on each of March 29, 2022, March 29, 2023 and March 29, 2024, such that the award will be fully vested March 29, 2024."}],"balance_after":21873,"derivative":{"exercise_price":17.24,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":21873},"source":{"system":"sec-edgar","filing":"0001209191-21-030446","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121030446/doc4.xml","form_type":"4"}},{"id":3033502,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":29041,"kind":"person","name":"MAXWELL LINDA","position":1,"cik":"0001822674","reported_name":"MAXWELL LINDA","relationship":{"director":true}}],"security":"Stock Options","published_at":"2020-09-11T12:02:10.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":20680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":20680,"derivative":{"exercise_price":102.44,"exercise_date":"2021-09-10","expiration_date":"2030-09-10","underlying":"Common Stock","underlying_shares":20680},"source":{"system":"sec-edgar","filing":"0001127602-20-024966","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760220024966/form4.xml","form_type":"4"}}]}